P1478Prognosis of cardiac sarcoidosis in patients with implantable cardioverter defibrillator -primary versus secondary prevention-
Explore this paper's citation graph
- Type
- article
- Published
- 2017-06-01
- Cited by
- 1
- References
- 0
- Access
- Open access
- OpenAlex
- https://openalex.org/W2718767706
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:80491305
Keywords
Medicine, Implantable cardioverter-defibrillator, Cardiac sarcoidosis, Cardiology, Secondary prevention
References
No references recorded for this paper.
Cited by
Related papers
- Complete atrioventricular block with a 22-month history of ocular sarcoidosis: a case report.
- Outcomes of ICD therapy for primary and secondary prevention indications
- Abstract 18593: Implantable Cardioverter-defibrillator for Sudden Cardiac Death Prevention in Korea: Results From a Nationwide Population-based Study
- A model predicted the benefits of hyperlipidemia and hypertension therapy in high-risk primary prevention and secondary prevention
- DRIVING RESTRICTIONS AND EARLY ARRHYTHMIAS IN PATIENTS RECEIVING A SECONDARY PREVENTION IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR (DREAM-ICD-II STUDY)
- Failure to Follow the Guidelines for Implantable Cardioverter Defibrillator in Primary Prevention of Sudden Death
- Comparison and predictors of implantable cardioverter-defibrillator therapy for primary and secondary prevention
- P950Psychological adjustment in patients with an implantable cardioverter defibrillator (ICD): primary prevention vs secondary prevention
- Rate of Appropriate and Inappropriate Therapy in Patients with Non-Ischaemic Cardiomyopathy, A Comparison between Primary and Secondary Prevention Implantable Cardioverter-Defibrillator Patients